https://www.selleckchem.com/pr....oducts/simufilam.htm
symptomatic carotid stenosis was associated with lower risk of stroke or death (3.0% vs 4.3%; RR 0.69 [95%CI 0.47-0.998]; P = .048), whereas there were no statistically significant differences in stroke or death with protamine use in asymptomatic patients (1.6% vs 1.0%; RR 1.63 [95%CI 0.67-3.92]; P = .28). Conclusions Heparin-reversal with protamine following transfemoral carotid artery stenting is not associated with an increased risk of thromboembolic events and its use in symptomatic carotid disease is associated with a lower risk
Like
Comment
Share
